Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin.

Leptin, a peptide hormone produced mainly in fat cells, appears to be important for the regulation of metabolism, insulin secretion/sensitivity and body weight. Recently, elevated plasma leptin levels have been reported in patients with arterial hypertension. Because a change in circulating leptin concentrations in such patients could be caused by altered rates of production or disposal, or both, the aim of the present study was to identify regions of leptin overflow into the bloodstream and of leptin extraction. Patients with arterial hypertension (n=12) and normotensive controls (n=20) were studied during catheterization with elective blood sampling from different vascular beds (artery, and renal, hepatic, iliac and cubital veins). Plasma leptin was determined by a radioimmunoassay. Patients with hypertension had significantly elevated levels of circulating leptin (12.8 ng/l, compared with 4.1 ng/l in the controls; P<0.001), and this was also the case when adjusted for body mass index (BMI) [0.435 and 0.167 ng/l per unit BMI (kg/m(2)) respectively; P<0.001]. Circulating leptin was directly related to arterial blood pressure (r=0.38-0.62, P</=0.05-0.005) and immunoreactive insulin (r=0.51, P<0.62), but not to plasma renin activity. A significant renal extraction ratio for leptin was seen in the hypertensive patients, but this was not significantly lower than that in the controls (0.09 compared with 0. 16; P=0.1). The hypertensive patients had a significantly higher hepatic venous/arterial leptin ratio than the controls (1.02 compared with 0.93; P<0.02), and this ratio was correlated directly with the BMI (r=0.38, P=0.05) and immunoreactive insulin (r=0.43, P<0.05). In both hypertensive patients and controls there was a significant spillover of leptin into the iliac vein, but not into the cubital vein. In conclusion, the high concentration of circulating leptin in patients with arterial hypertension is probably caused by increased release of leptin from abdominal (especially mesenteric and omental) and gluteal adipose tissue stores, and renal extraction is slightly reduced. Leptin kinetics in arterial hypertension require further investigation.

[1]  W. Sheu,et al.  High plasma leptin concentrations in hypertensive men but not in hypertensive women. , 1999, Journal of hypertension.

[2]  T. Tuomi,et al.  Serum and follicular fluid leptin during in vitro fertilization: relationship among leptin increase, body fat mass, and reduced ovarian response. , 1999, The Journal of clinical endocrinology and metabolism.

[3]  D. Seals,et al.  Neural mechanisms in human obesity-related hypertension. , 1999, Journal of hypertension.

[4]  J. Holst,et al.  Increased circulating leptin in alcoholic cirrhosis: Relation to release and disposal , 1999, Hepatology.

[5]  V. Somers,et al.  An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension. , 1999, Journal of hypertension.

[6]  L. Weinehall,et al.  Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. , 1999, Stroke.

[7]  A. Siewert-Delle.  Long-term renal function in primary hypertension. An epidemiological and pathophysiological study. , 1999, Scandinavian journal of urology and nephrology. Supplementum.

[8]  A. Więcek,et al.  Pathophysiological role of leptin in patients with chronic renal failure, in kidney transplant patients, in patients with essential hypertension, and in pregnant women with preeclampsia. , 1999, Artificial organs.

[9]  T. Saruta,et al.  The obese gene product, leptin: possible role in obesity‐related hypertension in adolescents , 1998, Journal of hypertension.

[10]  R. Freeman,et al.  Renal effects of leptin in normotensive, hypertensive, and obese rats. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[11]  P. Suter,et al.  Is there a role for the ob gene product leptin in essential hypertension? , 1998, American journal of hypertension.

[12]  A. Distler,et al.  Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men , 1998, Journal of hypertension.

[13]  G. Frühbeck,et al.  Leptin: physiology and pathophysiology. , 1998, Clinical physiology.

[14]  G. Marchesini,et al.  Gender-dependent alterations in serum leptin in alcoholic cirrhosis. , 1998, Gastroenterology.

[15]  D. Seals,et al.  Leptin in human plasma is derived in part from the brain, and cleared by the kidneys , 1998, The Lancet.

[16]  F. Anania,et al.  Transdifferentiation of rat hepatic stellate cells results in leptin expression. , 1998, Biochemical and biophysical research communications.

[17]  S. Brichard,et al.  Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity. , 1998, The Journal of clinical endocrinology and metabolism.

[18]  A. Mark,et al.  CARDIOVASCULAR CONSEQUENCES OF OBESITY: ROLE OF LEPTIN , 1998, Clinical and experimental pharmacology & physiology.

[19]  J. Hall,et al.  Chronic leptin infusion increases arterial pressure. , 1998, Hypertension.

[20]  J. Friedman.  Leptin, leptin receptors and the control of body weight. , 2009, European journal of medical research.

[21]  Huiqing Lu,et al.  Intracerebroventricular Leptin Increases Lumbar and Renal Sympathetic Nerve Activity and Blood Pressure in Normal Rats , 1997, Diabetes.

[22]  Y. Miyazaki,et al.  High plasma immunoreactive leptin level in essential hypertension. , 1997, American journal of hypertension.

[23]  B. Zinman,et al.  Serum Immunoreactive Leptin Concentrations in a Canadian Aboriginal Population With High Rates of NIDDM , 1997, Diabetes Care.

[24]  Graham M Lord,et al.  Plasma immunoreactive leptin concentration in end-stage renal disease. , 1997, Clinical science.

[25]  Y. Yoshimasa,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Glucocorticoid Regulation of Leptin Synthesis and Secretion in Humans: Elevated Plasma Leptin Levels in Cushing’s Syndrome* , 2022 .

[26]  M. Laakso,et al.  Leptin concentrations, sex hormones, and cortisol in nondiabetic men. , 1997, The Journal of clinical endocrinology and metabolism.

[27]  H. Baum,et al.  Removal of endogenous leptin from the circulation by the kidney , 1997, International Journal of Obesity.

[28]  T. Shoji,et al.  Renal function and insulin resistance as determinants of plasma leptin levels in patients with NIDDM , 1997, Diabetologia.

[29]  W. Garvey,et al.  The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. , 1997, The Journal of clinical endocrinology and metabolism.

[30]  S. Klein,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Increased Plasma Leptin Concentration in End-Stage Renal Disease* , 2022 .

[31]  H. Baum,et al.  Leptin is cleared from the circulation primarily by the kidney. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[32]  R. Considine,et al.  Leptin: The Tale of an Obesity Gene , 1996, Diabetes.

[33]  S. Klein,et al.  Radioimmunoassay of leptin in human plasma. , 1996, Clinical chemistry.

[34]  S. Mudaliar,et al.  Acute and Chronic Effect of Insulin on Leptin Production in Humans: Studies In Vivo and In Vitro , 1996, Diabetes.

[35]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[36]  Rene Devos,et al.  Identification and expression cloning of a leptin receptor, OB-R , 1995, Cell.

[37]  J. Auwerx,et al.  Transient increase in obese gene expression after food intake or insulin administration , 1995, Nature.

[38]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[39]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[40]  J. Henriksen,et al.  Noninvasive 24‐hour ambulatory arterial blood pressure monitoring in cirrhosis , 1995, Hepatology.

[41]  C. Christiansen,et al.  Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. , 1995, Metabolism: clinical and experimental.

[42]  J. Henriksen,et al.  Hepatic extraction of the aminoterminal propeptide of type III procollagen before and after bile duct ligation in pigs. , 2008, Liver.

[43]  N. Christensen,et al.  Continuous infusion of tracer norepinephrine may miscalculate unidirectional nerve uptake of norepinephrine in humans. , 1989, Circulation research.

[44]  N. Christensen,et al.  Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. , 1984, Gut.

[45]  R. Turner,et al.  A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. , 1972, Acta endocrinologica.